# Processa (PCSA) — News PCSA · NASDAQ · Stock Canonical page: https://www.lighthorse.io/tickers/pcsa/news ## Recent headlines - [LPP - Launch of TCZew logistics center planned for turn of Q1 and Q2 of 2027](https://www.ainvest.com/news/lpp-launch-tczew-logistics-center-planned-turn-q1-q2-2027-2610) — AInvest Wire, Oct 13, 2026 LPP SA, the Polish clothing company, has announced plans to launch its new TCZew logistics center at the turn of Q1 and Q2 of 2027. The facility is expected to play a key role in supporting the company’s ongoing expansion strategy, particularly in South-Eastern Europe. This follows the recent… - [Processa Pharmaceuticals - Offers 306,574,202 shares of common stock for resale - SEC filing](https://www.ainvest.com/news/processa-pharmaceuticals-offers-306-574-202-shares-common-stock-resale-sec-filing-2610) — AInvest Wire, Oct 9, 2026 Processa Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) to offer 306,574,202 shares of its common stock for resale [1]. The filing, made under a registration statement, indicates the company is seeking to facilitate the public offering of these shares, which may… - **Important** — [Processa Pharmaceuticals announces closing of $5 million public offering priced at-the-market under Nasdaq rules](https://www.ainvest.com/news/processa-pharmaceuticals-announces-closing-5-million-public-offering-priced-market-nasdaq-rules-2501) — AInvest Wire, Jan 30, 2025 Processa Pharmaceuticals announces closing of $5 million public offering priced at-the-market under Nasdaq rules Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company specializing in the development of next-generation chemotherapeutic drugs, announced the successful… - **Important** — Processa stock rallies 35% post-market on Phase 2 study update — AInvest Wire, Oct 2, 2024 Processa stock rallies 35% post-market on Phase 2 study update Processa Pharmaceuticals, a clinical-stage pharmaceutical company focused on improving cancer treatment outcomes, recently announced successful outcomes from a meeting with the U.S. Food and Drug Administration (FDA) regarding the… - **Important** — Processa Pharmaceuticals Shares Drop 20% After Pricing Offering — AInvest Wire, Jan 26, 2024 Processa Pharmaceuticals Shares Drop 20% After Pricing Offering Processa Pharmaceuticals, a clinical-stage pharmaceutical company, recently announced that it will effect a 1-for-20 reverse stock split [1]. The company's Board of Directors determined the split ratio on January 8, 2024, and the… --- Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express. This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness. Data provided by [AInvest](https://www.ainvest.com).